"Innovation Should Be Given a Boost Through Tax Incentives"
In the middle of the current pandemic, India has emerged as a credible supplier of essential medicines
- May 27, 2020,
- Updated May 28, 2020 9:37 AM IST
Four Indian pharma companies have just signed a partnership agreement with US-based Gilead for supply of its experimental coronavirus drug Remdesivir. Satish Reddy, President, Indian Pharmaceutical Alliance (which represents 24 leading pharma firms) and Chairman of Dr. Reddy's Laboratories, speaks to Business Today's Joe C. Mathew about how home-grown firms are serving India and the world during the Covid-19 crisis. Edited excerpts.
Four Indian pharma companies have just signed a partnership agreement with US-based Gilead for supply of its experimental coronavirus drug Remdesivir. Satish Reddy, President, Indian Pharmaceutical Alliance (which represents 24 leading pharma firms) and Chairman of Dr. Reddy's Laboratories, speaks to Business Today's Joe C. Mathew about how home-grown firms are serving India and the world during the Covid-19 crisis. Edited excerpts.